Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Galera Therapeutics Inc.

www.galeratx.com

Latest From Galera Therapeutics Inc.

VC Roundup: Flagship’s New Fund Designed To Raise Its Stake In Startups

Newly renamed Flagship Pioneering has raised a $285m venture capital fund to remain invested in portfolio companies as they grow. Also, 12 new and growing biopharma companies raised $657.15m.

Commercial StartUps and SMEs

Venture Funding Deals, November 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2015.

BioPharmaceutical Medical Device

Start-Up Quarterly Statistics, Q4 2012

Start-ups raised a total of $670.3 million across all industries in Q4 2012, just $11.6 million less than in Q3, and 90% of that money went to biopharma companies. Several start-up companies inked deals with Big Pharmas, and there were three acquisitions – two in biopharma and one in the device sector.

BioPharmaceutical Medical Device

Financings Of The Fortnight: Too Soon To Size Up Impact Of The U.S. JOBS Act

Plus news on recent financings by Onyx Therapeutics, InterMune, Versartis and Aileron Therapeutics.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Dental & Oral Products
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Galera Therapeutics Inc.
  • Senior Management
  • J. Mel Sorensen, MD, Pres. & CEO
    Joel Sussman, CFO
    Robert A Beardsley, PhD, COO
    Dennis P Riley, PhD, CSO
    Jon T Holmlund, MD, CMO
  • Contact Info
  • Galera Therapeutics Inc.
    Phone: (610) 725-1500
    2 West Liberty Blvd.
    Ste. 110
    Malvern, PA 19355
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register